Farmaci: principali
Società Società Argentina che operano nel settore: farmaci: principali
L'elenco seguente contiene le Società Argentina che operano nello stesso settore, farmaci: principali. L'elenco aiuta a monitorare la loro performance, il bilancio economico e altro ancora. Ordinato in base a tutte le metriche necessarie, può mostrare i titoli più costosi del settore, come le ASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25, o quelli con la migliore dinamica dei prezzi, come le GSK PLC CEDEAR EACH REPR 1/4 ADR (USD), contribuendo così alla progettazione di strategie di qualsiasi tipo.
Simbolo | Cap mercato | Prezzo | Variazione % | Volume | Volume rel | P/E | EPS dil TTM | EPS diluito crescita TTM YoY | Rendimento div % TTM | Settore | Rating analisti |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1DR | 647.207 T ARS | 14682.000 ARS | −2.08% | 2.872 K | 1.16 | — | — | — | — | Tecnologia sanitaria | — |
| LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 647.207 T ARS | 15.350 USD | +8.87% | 8 | 0.12 | — | — | — | — | Tecnologia sanitaria | — |
 JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHSDR | 318.306 T ARS | 10790.500 ARS | −0.33% | 12.83 K | 1.24 | 55.37 | 194.88 ARS | +348.94% | 0.84% | Tecnologia sanitaria | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 318.306 T ARS | 1210.000 ARS | +0.41% | 3 | 0.00 | — | — | — | — | Tecnologia sanitaria | — |
| JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 318.306 T ARS | 10.400 USD | −0.95% | 349 | 0.73 | 45.69 | 194.88 ARS | +19.44% | 0.84% | Tecnologia sanitaria | — |
 MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50)DR | 291.127 T ARS | 28071.500 ARS | −0.33% | 207 | 0.07 | — | — | — | — | Tecnologia sanitaria | — |
 ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COMDR | 249.996 T ARS | 17299.500 ARS | −0.24% | 980 | 0.35 | 12.21 | 1417.30 ARS | +131.65% | 1.68% | Tecnologia sanitaria | — |
| ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 249.996 T ARS | 18.000 USD | +5.88% | 11 | 0.72 | 10.87 | 1417.30 ARS | −38.37% | 1.68% | Tecnologia sanitaria | — |
 AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25DR | 211.221 T ARS | 41827.500 ARS | −0.51% | 264 | 0.27 | 105.52 | 396.38 ARS | +306.81% | 1.01% | Tecnologia sanitaria | — |
| AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD) DR | 211.221 T ARS | 41.800 USD | +7.18% | 4 | 0.74 | 90.29 | 396.38 ARS | +8.24% | 1.01% | Tecnologia sanitaria | — |
 NVSNOVARTIS AG CEDEAR EACH 4 REP 1DR | 174.514 T ARS | 27593.000 ARS | +1.34% | 698 | 5.71 | — | — | — | — | Tecnologia sanitaria | — |
 AMGNAMGEN INC CEDEAR EACH 30 REP 1DR | 148.128 T ARS | 11158.000 ARS | −1.64% | 963 | 0.12 | — | — | — | — | Tecnologia sanitaria | — |
| AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD) DR | 148.128 T ARS | 10.700 USD | −2.73% | 12 | 0.39 | — | — | — | — | Tecnologia sanitaria | — |
 PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05DR | 140.94 T ARS | 7561.500 ARS | −1.11% | 9.858 K | 0.35 | — | — | — | — | Tecnologia sanitaria | — |
| PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 140.94 T ARS | 7.300 USD | 0.00% | 901 | 0.75 | — | — | — | — | Tecnologia sanitaria | — |
 GSKGSK PLC CEDEAR EACH REPR 1/4 ADRDR | 80.223 T ARS | 12137.000 ARS | +0.65% | 270 | 0.66 | 42.43 | 286.03 ARS | −2.78% | 1.23% | Tecnologia sanitaria | — |
| GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD) DR | 80.223 T ARS | 12.000 USD | +16.50% | 25 | 0.86 | 35.92 | 286.03 ARS | −74.13% | 1.23% | Tecnologia sanitaria | — |
 BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1DR | 80.046 T ARS | 16161.000 ARS | −0.09% | 1.73 K | 1.87 | — | — | — | — | Tecnologia sanitaria | — |
| BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 80.046 T ARS | 15.050 USD | −2.27% | 2 | 0.39 | — | — | — | — | Tecnologia sanitaria | — |
 BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005DR | 28.625 T ARS | 18434.500 ARS | −0.72% | 51 | 0.04 | — | — | — | — | Tecnologia sanitaria | — |
 RICHLABORATORIOS RICHMOND SACIF | 72.555 B ARS | 893.000 ARS | −0.61% | 11.154 K | 1.54 | — | −46.54 ARS | — | 0.00% | Tecnologia sanitaria | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 5.099 B ARS | 121.500 ARS | +1.46% | 3.213 K | 0.83 | — | — | — | 0.00% | Tecnologia sanitaria | — |